Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278031
Status:
UNKNOWN
Last Update Posted:
2016-10-04
First Post:
2006-01-17
Brief Title:
Quality of Life in Children Cured of Retinoblastoma
Sponsor:
Hadassah Medical Organization
Organization:
Hadassah Medical Organization
Study Overview
Official Title:
Quality of Life in Children Cured of Retinoblastoma
Status:
UNKNOWN
Status Verified Date:
2016-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to assess the quality of life of children who have been cured of retinoblastoma - a malignant eye tumor The study is questionnaire-based and uses standardized quality of life assessment tools
Detailed Description:
Retinoblastoma is the most common eye tumor of children It can present in one eye unilateral or in both eyes bilateral The bilateral form is always hereditary
Retinoblastoma is a highly curable tumor Using a combination of surgery chemotherapy radiation and local treatment modalities to the eye over 98 of patients are cured This means that most children diagnosed with retinoblastoma will become long-term survivors
The use of surgery taking out one eye chemotherapy and radiation may be associated with long term side-effects some of which may have significant impact on the quality of life of the child In addition in case where the disease is hereditary additional psychological issues arise
The aim of our study is to assess in a comprehensive and standardized fashion the long term quality of life in children who were treated for retinoblastoma and who are currently alive and well
The assessment will include the use of questionnaires that assess quality of life as well as participation in age-appropriate activities
Each child and hisher parent will be interviewed and the questionnaires completed The process will take about one hour for each child No risk or discomfort to the child is involved
Retinoblastoma is a highly curable tumor Using a combination of surgery chemotherapy radiation and local treatment modalities to the eye over 98 of patients are cured This means that most children diagnosed with retinoblastoma will become long-term survivors
The use of surgery taking out one eye chemotherapy and radiation may be associated with long term side-effects some of which may have significant impact on the quality of life of the child In addition in case where the disease is hereditary additional psychological issues arise
The aim of our study is to assess in a comprehensive and standardized fashion the long term quality of life in children who were treated for retinoblastoma and who are currently alive and well
The assessment will include the use of questionnaires that assess quality of life as well as participation in age-appropriate activities
Each child and hisher parent will be interviewed and the questionnaires completed The process will take about one hour for each child No risk or discomfort to the child is involved
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None